VetSurgeon.org has launched a survey to discover what veterinary professionals think of the food available for small furries, and how it is labelled.
The survey closes on 22nd September, when one completed survey entry will be drawn from the hat to win £50 worth of John Lewis shopping vouchers.
The survey consists of nine quick questions, which should only take a few moments to complete.
Click here to take part in the survey.
Free places on Vétoquinol's webinar: 'Chronic Pain in the Geriatric Dog: Decision Making and Risk Management' are going fast, according to the company, and those wishing to attend are being advised to register as soon as possible.
Vétoquinol says that at one point, 200 vets registered in just 3 hours, demonstrating the extent to which vets are finding this to be a challenging topic when it comes to managing their day to day case load.
The webinar takes place at 8.30pm on Wednesday 15th June 2011 and the talk is being delivered by Dr. Jo Murrell, Senior Lecturer in Veterinary Anaesthesia at Bristol Vet School and holder of The European Diploma in Veterinary Anaesthesia and Analgesia. She said: "Decision making can be a complex business when so many factors have to be taken into account. We all see geriatric dogs with painful conditions reasonably frequently and concurrent diseases are common. I will be aiming to describe a way to balance out the risks and benefits, to take into account client's concerns and develop a more logical, rational approach to treatment."
To register for the free webinar go to www.thewebinarvet.com/vetoquinol. Enter the code veto11 to obtain the webinar free of charge.
The British Equine Veterinary Association (BEVA) is urging veterinary surgeons to be on the lookout for outbreaks of Atypical Myopathy (AM) this spring.
Atypical Myopathy is a serious muscle disease found in the UK and Northern Europe. It is linked to horses eating the seeds from trees in the Acer family, including sycamore and box elder. There were more than five times as many cases of AM last autumn than in the previous year and experts have warned that the disease tends to occur more frequently in the spring following an autumn surge, possibly because of the growth of seedlings. The prognosis is poor, with survival rates of less than 25%. Early diagnosis is essential to give the best chance of survival.
Horses that develop AM are usually kept on sparse pastures, near trees from Acer pleudoplatanus (sycamore) or Acer negundo (box elder, pictured right) that shed seeds containing the toxin hypoglycin A. They are often not fed any supplementary hay or feed and may be driven to browse on an accumulation of dead leaves, dead wood and trees in or around the pasture but sometimes well-fed animals are affected. While the tree seeds may not be directly palatable, horses on poor quality grazing may ingest considerable numbers of them.
The clinical signs of AM may include muscle weakness or stiffness, colic-like symptoms, laboured breathing, dark red-brown urine, recumbency or even sudden death. Often the disease will present as an outbreak. Confirmation of diagnosis is by a blood or urine test. The toxin directly targets aerobic energy metabolism so therapy should be targeted at promoting glucose metabolism and provided fluid dieresis.
Preventative advice for horse owners includes:
Professor Celia Marr, Partner at Rossdales, Newmarket, European Specialist in Equine Internal Medicine and Editor of Equine Veterinary Journal said: "New, collaborative research, instigated last year between the University of Liege, the Irish Equine Centre and the Animal Health Trust should shed more light on the characteristics of the disease in this country. Once we know more about the specific causes we should be able to make more positive progress with prevention strategies."
BEVA has provided free online access to two articles from the journal of Equine Veterinary Education on the disease for all vets to help them address the threat.
Volume 25, Issue 5, pages 264-270, May 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 1: First aid, cardiovascular, nutritional and digestive care (pages 264-270) G. van Galen and D -M Votion.
Volume 25, Issue 6, pages 308-314, June 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 2: Muscular, urinary, respiratory and hepatic care, and inflammatory/infectious status (pages 308-314) G van Galen and D - M Votion.
Investigation of the relationship between ionised and total calcium in dogs with ionised hypercalcaemia1 was undertaken by Tørnqvist-Johnsen et al. at the Hospital for Small Animals, University of Edinburgh, UK.
Initially, a normal reference interval for ionised calcium, total calcium and albumin, serum and plasma biochemistry was established by analysing samples from 351 healthy adult dogs.
After establishing a reference interval for ionised calcium, the laboratory’s database was searched for adult dogs with ionised hypercalcaemia that had attended the university small animal hospital between 2012 and 2017, a time frame when the same sample handling protocols and instrumentation was in use. The hospital records were searched for patient information and the biochemical parameters statistically analysed.
Of 63 dogs identified with ionised hypercalcaemia, 23 did not have a total hypercalcaemia (37%). 16 of these 23 dogs (70%) had albumin within the reference interval. To summarise the key findings; using total calcium, one third of patients with ionised hypercalcaemia were not identified. There was also no significant relationship between albumin and total calcium in these cases.
Camilla Tørnqvist-Johnsen, lead author of the paper, said: "Hypercalcaemia is a very important clinical abnormality, often revealing severe underlying disease in dogs who do not get idiopathic hypercalcaemia. This study reveals the true importance of doing an ionised calcium measurement when evaluating calcaemic status."
Nick Jeffery, Editor of JSAP said: "This study demonstrates that, if relying on total calcium alone, more than one third of dogs with ionised hypercalcaemia will be classified as normocalcaemic. Furthermore, the study demonstrates that the discordance between ionised and total calcium cannot be routinely explained by a low protein-bound component.
"Whilst reference intervals are key in clinical practice to determine whether a result is an outlier from 95% of a healthy population, it is not inevitable that a patient with an outlying biochemical test result has a clinically relevant disease."
The full article can be found in the April issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13109
Reference
Helen Ghosh, Defra's Permanent Secretary today confirmed the appointment of Nigel Gibbens as Chief Veterinary Officer (CVO). Nigel qualified as a veterinary surgeon in 1981 and has spent most of his career involved in animal health and welfare with lead roles on international trade and exotic diseases. Since 1990 he has held a variety of operational and advisory positions in the Government's veterinary and policy services. Nigel moved to the central animal health policy group in 1996 and worked on international trade for eight years, followed by surveillance and control of Bovine Spongiform Encephalopathy and animal welfare. He has also worked in general veterinary practice and for Government veterinary services in Belize and Yemen. He said: "I am delighted to have been appointed to this important and challenging role. I intend to build on the successes and lessons learned from recent exotic disease outbreaks to ensure that these risks continue to be managed as effectively as possible. "Defra and its Agencies must continue to work with animal keepers and the veterinary profession to deal with existing challenges such as Bluetongue and Tuberculosis, and to maintain good animal welfare standards and surveillance to identify and deal with any new threats. The Government will increasingly develop policy on disease control in partnership with key stakeholders and I am committed to ensuring that those decisions are founded on the best possible veterinary advice." Nigel's first event as CVO will be to represent the UK at the World Animal Health Organisation General Session in Paris from 25 to 30 May.
Pedigree® has announced the launch of national Oral Care Month, which will take place during March 2010.
Recognising that canine periodontal disease affects over 80% of dogs in the UK, yet with only 2% of owners following a regular oral care regime for their dog, Oral Care Month will seek to encourage owners to visit their veterinary practice for free dental check-ups.
The company says the initiative will be supported with a wide range of marketing material for practices, including striking waiting room posters, leaflets and free Pedigree DentaStix samples. A far-reaching national press and TV advertising campaign will also take place leading up to the campaign to encourage existing and potentially new clients to seek advice from their vet.
Pedigree's oral care expert, Dr Marie-Louise Baillon says that most owners simply aren't aware that four out of five dogs over the age of three are likely to have gum disease. "We've found that around 90% of owners rate their own dog's teeth and gums as being either good or perfect. What our campaign is aiming to do is educate owners to look out for the telltale signs, such as bad breath, which many will often wrongly accept as being normal, or bleeding and inflamed gums."
Practices can sign up to Oral Care Month from 1st January at: http://www.oralcaremonth.co.uk/.
Promotional materials will be sent to registered surgeries in the New Year. All practices that sign up will be listed on the campaign's consumer website so that dog owners can easily find their nearest participating vet.
All registered Oral Care Month practices will also be entered into a free prize draw. Prizes include a dental X-ray system worth £2,500, 25 free places on next year's 'Improving Periodontal Health' autumn lecture tour and 50 periodontal probes.
A poll carried out by The Children's Mutual has found that becoming a veterinary surgeon is one of the most popular career ambitions for 5-7 year olds, second only to becoming a teacher.
The Children's Mutual questioned over a thousand parents about what their children said they wanted to be when they grew up and found that the majority of today's children are looking for a career which requires further training and education. The top careers of doctor, teacher and vet have featured in the 'What I Want To Be' poll for the last three years, demonstrating that children consistently aspire to careers that will need higher education.
However, if you want your children to follow in your footsteps as a vet, you might like to start setting something aside now. According to The Children's mutual, it currently costs £74,700 to train to become a doctor and £75,100 to become a vet but these are set to increase by around £41,000 based on current projection levels over the next 18 years.
The top 10 career ambitions in 2010 (2009 in brackets) were:
Tony Anderson, Marketing Director of The Children's Mutual, said: "The children questioned for our research are lucky enough to have a Child Trust Fund account and with half of accounts opened with us receiving additional savings on a monthly basis, we hope these children face brighter financial futures. The question going forward is how parents will fill the savings black hole for children born from January 2011 if the Child Trust Fund is scrapped."
The Veterinary Marketing Association is running a free seminar on Thursday 24th November from 5-7pm for any delegates of the London Vet Show, or those in the vicinity, that feel they'd like to learn about the principles of marketing.
The VMA says that in today's competitive environment, the key to success for a veterinary business is often making oneself heard and standing out above the competition, but questions how many vets are taught any marketing at college or whether marketing is something that most vets just pick up over time?
The VMA's Principles of Marketing seminar will aim to address the basics in marketing, with an emphasis on the veterinary sector. It's taking place at the Hilton Hotel, London Olympia, a few minutes walk from the show.
The VMA has enlisted the services of Paul Fifield (Visiting Professor in Marketing Strategy at the Southampton University School of Management) to deliver the seminar.
This event is open to anyone and entry is free. As spaces are limited to a maximum of 60, registration is strongly advisable. For more information, or to register, please visit the VMA's website - http://www.vma.org.uk/.
The seminar will be followed by a free buffet and time for questions.
Everyone taking part in the survey will receive a fob watch to thank them for their participation.
Sarah is leading the project, which is supported by Ceva Animal Health, alongside Professor Danièlle Gunn-Moore, fellow RCVS Feline Medicine Specialist and Professor in Feline Medicine at The University of Edinburgh.
Suzanne Page MRCVS, Amodip Product Manager at Ceva, said: “There are many barriers to ensuring that all older cats and those with relevant concurrent diseases receive screening for hypertension.
"The survey will help us better understand what those barriers are and how these challenges can be addressed positively to improve animal welfare.
"It is also an issue that requires the whole practice team to come together to deliver a better outcome for their patients.
"We are therefore very keen to find out how all members of the practice team view these important issues and want to encourage all vets and veterinary nurses to share their perspective on the challenges they face in carrying out blood pressure measurements.”
Sarah is emphasising the importance of keeping feline patients calm and relaxed during blood pressure assessments: “The so-called ‘white coat effect’ or situational hypertension, has been observed in both people and animals.
"The survey will also explore the tools and techniques veterinary professionals use to minimise the impact of blood pressure assessments on their patients and will help us to develop some best practice approaches.”
The survey can be found at https://bit.ly/FelineHypertensionSurvey.
The British Veterinary Association has welcomed the British Veterinary Nursing Association and the Veterinary Practice Management Association as Affiliate members.
Affiliate and Associate are newly activated BVA membership categories, and the election of BVNA and the VPMA as Affiliates also encourages any of their suitably qualified members to apply for Associate membership of the BVA.
According to the BVA, Affiliate status in no way affects an organisation's own remit and responsibilities towards its members. What it does mean is that Affiliates can benefit from the BVA's knowledge and expertise in such areas as lobbying and marketing.
In welcoming BVNA and VPMA newly elected BVA President Nicky Paull said: "I am delighted that my Presidential year coincides with the BVA family embracing both veterinary nurses and veterinary practice managers. Both are integral members of the veterinary team and we believe that our new relationship will bring lasting benefits to all parties. BVA looks forward to supporting our new Affiliates in promoting the professionalism of both veterinary nursing and veterinary practice management not only within the profession but to the wider community.
These are exciting, if challenging times, for the veterinary community world-wide and I have no doubt that our new relationship will strengthen not only our individual associations but the profession as a whole."
The RCVS reports that the Department for Environment, Food and Rural Affairs (Defra) has now finalised the new microchip regulations for England, which include a provision that dog breeders and other individuals who wish to implant microchips and have no previous approved training, must undergo a compulsory training course.
While veterinary surgeons were exempted from this training, Defra initially envisaged that veterinary nurses would be required to undertake it. In a joint letter, that was followed by negotiations with Defra, the Royal College of Veterinary Surgeons (RCVS), the British Veterinary Association (BVA) and the British Veterinary Nursing Association (BVNA), stressed that registered veterinary nurses are already sufficiently trained to be able to safely implant a microchip, and would be doing so under the direction of a veterinary surgeon.
Defra subsequently has agreed that registered veterinary nurses are already sufficiently qualified to implant microchips, and will therefore be exempt from further training requirements when new legislation comes in for England. Wales and Scotland are currently considering the details of implementation.
The Royal College says it is also aware of new Defra microchipping guidelines for England which make it compulsory to report adverse reactions (including migration from the site of implantation) or the failure of a microchip. Gordon Hockey, RCVS Registrar, said: "There is some concern in the profession about this requirement, but Defra have said that they would not enforce this regulation via the courts, or seek to impose fines. The RCVS is likely to amend its supporting guidance later this year to clarify that veterinary surgeons should make appropriate reports, similar to reports for adverse reactions to veterinary medicines. In each case reports can be made online to the Veterinary Medicines Directorate."
To help veterinary surgeons and veterinary nurses, as well as practices, raise awareness of owners' legal obligation to microchip their dogs, the BVA has posters available for all three regions (England, Scotland and Wales) that can be displayed in waiting rooms and surgeries. The posters are available to download from the BVA website: www.bva.co.uk.
BVA President John Blackwell said: "As a founding member of the Microchipping Alliance, which campaigned for compulsory microchipping together with dog welfare organisations, local authorities and others, BVA is delighted with the progress that has been made and it is very good indeed to be less than a year away from mandatory microchipping across the UK.
"But this is where the work begins for veterinary surgeons and nurses. We need to work hard to make owners aware of the new law throughout this year, with animals microchipped as far in advance of the deadline as possible.
"We also need to ensure that microchipping does the job it is intended to do. This process will be helped very much by not compelling veterinary nurses to undertake additional training when they already undertake minor acts of veterinary surgery that are much more complex procedures than implanting a microchip."
The company says the main breakthrough in this new authorisation is that the dose for cattle has been reduced from 4 ml to 2 ml, improving convenience and aligning with the latest regulatory data.
In cattle, the vaccine is indicated for active immunisation to reduce viraemia caused by BTV-3.
The onset of immunity is 3 weeks after completing the primary vaccination course.
The vaccine can be given to cattle from 2 months of age in naïve animals, or from 3 months if born to immune dams.
For the primary vaccination, two doses of 2ml are given, 3 weeks apart, intramuscularly.
In sheep, the vaccine is indicated for active immunisation to reduce viraemia, mortality, clinical signs and lesions caused by BTV-3.
The onset of immunity is 4 weeks after completing the primary vaccination course.
The vaccine can be given to sheep from 3 months of age, subcutaneously.
For the primary vaccination, one dose of 2 ml is given.
https://syva.es/en/
The Company of Animals, makers of behaviour and training products, has announced the launch of a new Product and Training DVD, designed to be screened in practice waiting rooms. The DVD features the entire range of products from Company of Animals, including its multi-award-winning dog training devices, being demonstrated by pet dogs and their owners. It is presented by Animal Psychologist and founder of The Company of Animals, Dr. Roger Mugford. The Company of Animals says that playing the DVD during opening hours will grab the attention of your customers, raise their awareness of already popular products, and educate them about new ones. This DVD is free and available to all veterinary retailers. To order the DVD or for more information see: http://www.companyofanimals.co.uk/
Drontal has renewed sponsorship agreements with councils throughout the UK in a bid to further encourage pet owners to scoop their dogs' poop.
The support will see thousands of council dog bins featuring Drontal branding to promote best practice amongst dog owners and urge them to clean up after their pets.
Dan White, product manager for Drontal, said: "Through our dog bin sponsorship we are highlighting the importance of responsible pet ownership which includes preventing the spread of worm eggs in the environment by scooping poop."
According to Bayer, Drontal is the only wormer that kills every type of intestinal worm commonly found in UK dogs and cats.
For further information please contact your Bayer representative or log on to www.drontal.com.
Some say he pees Propofol, and that he once proposed to a Black Welsh Mountain Sheep called Blodwen. All we know is he's called The Stinge, and that he's challenged veterinary surgeons and nurses to beat his lap time in an electronic 'reasonably priced car' at the Alstoe Animal Health stand (G40) at the London Vet Show.
Alstoe says that for legal reasons (and because it doesn't have the money), The Stinge's better known cousin from BBC's Top Gear will not be making an appearance.
However the company is able to run to a bottle of champagne for the vet or nurse that sets the best lap time each day of the show.
Niall McFerran from Alstoe said: "Believe me, the Stinge is not a fast driver, so I think it will be very easy for the first contestant to beat him/her! The real question will be who is actually fastest each day. We are looking forward to having some fun".
The Libel Reform Campaign is asking supporters to lobby their MP to make sure that a reform of libel law gets into next year's Queen's Speech, which sets the legislative agenda for 2012.
Two cases in particular serve to highlight the impact of current law on the open discussion of medical science, that of the British Chiropractic Association vs Simon Singh (the author and Guardian journalist) and Matthaias Rath, a vitamin pill manufacturer vs Ben Goldacre (also an author and Guardian journalist).
The proposed new law will, amongst other things, help safeguard free and robust debate about veterinary science, so I urge you to lobby your MP. You can do that by clicking here.
A review of past research papers on the treatment of feline diabetes carried out by Dr Stijn Niessen at the RVC has found that much of the research into the condition was based on low-level evidence, lacked a cooperative approach and, therefore, yielded questionable results.
According to Dr Niessen, current recommendations are often based on previous research studies which used small sample sizes; some included as little as 8 cats. The biggest sample sizes found contained from 50 to 60 cats, but Dr Neissen says that even this isn't a big enough sample size to yield effective results. He says that so-called power calculations, a statistical test performed as part of this new publication, indicate that at least 80-90 animals are needed to accurately compare the effectiveness of different insulin types and other treatments.
Stijn said: "The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.
"This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits.
"Current research into the condition is sporadic, lacking a long-term vision and not collaborative. A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition. The owner could then go online and find a third way. These treatments aren't necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way. This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."
For more information, visit: https://www.facebook.com/RVC.Diabetic.Remission.Clinic
In addition to its Helpline service, Vetlife continued to provide mental health care through its Health Support service.
In 2023, the service facilitated 198 referrals, connecting individuals with mental health care resources.
The charity also provided over £100,000 of financial support to members of the profession who were facing financial hardship.
Trustee Danny Chambers said: "Within the veterinary community, there is a profound sense that Vetlife belongs to all of us.
"With over 4000 of our friends and colleagues reaching out for support within just 12 months, we urgently need your assistance to ensure this invaluable service continues.
"By becoming a 'Friend of Vetlife' with a monthly contribution from just £2.10—less than the cost of a cup of coffee—you provide us with a steady, predictable income, enabling us to plan and deliver long-term, consistent support to our veterinary community."
https://www.vetlife.org.uk/become-a-vetlife-member
Thousands of shipments of equine germinal product (semen, ova or embryos) are imported into the UK every year. It is a legal requirement for all imported equine semen to be accompanied to the place of destination (usually to the side of the mare) by an original, valid health certificate (ITAHC), issued in the country of origin.
The BEVA says that recently, consignments of equine semen have been imported without the appropriate health certificates meaning that there is no guarantee that the semen is free from the stated diseases or even that it is from the chosen stallion.
According to the Association, some well-known importing agents have been advising mare owners that these certificates are unnecessary and openly criticising veterinary surgeons who refuse to inseminate mares with uncertified imported semen.
The use of uncertified semen risks recipient mares being infected with diseases such as CEM or EVA, the potentially rapid spread of disease in breeding stock and eventual restrictions being placed on breeding premises. Recent outbreaks of Equine Infectious Anaemia (EIA) in Europe have increased the threat to the UK herd.
The personal and professional reputation of any veterinary surgeon involved with using uncertified semen is also in danger, with the RCVS likely to take a stringent line with any vets who disregard animal health laws and the high health status of British horses.
Malcolm Morley, Partner at Stable Close Equine Practice was recently placed in a difficult position with a longstanding client when semen arrived without the requisite documentation. Following a discussion between the semen importer and his client, where the client was told that Malcolm was being pedantic and that the client should find someone else to inseminate the mare, Malcolm contacted the importer saying: "We have no intention of inseminating the mare without the correct health papers. Please will you ensure that when you speak to the mare’s owner that you make it clear that you do not expect us to inseminate the mare in these circumstances and that the health papers should have been shipped with the semen."
Another BEVA member who wishes to remain anonymous said: "I have one very big client I think I may be about to lose because of my refusal to inseminate his mare without papers … (the importing stud) did not feel it worth a three hour drive to get papers done. The semen importer has made it clear to my client that (they believe) I am just being awkward."
Mark Bowen Senior Vice president of BEVA said: "Import agencies have placed additional pressure on the vets to inseminate mares without the necessary paperwork. Not only is this action illegal but places recipient mares under a direct threat from a notifiable and incurable disease. This seems particularly cavalier given the recent outbreaks of EIA across Europe."
Tullis Matson, Founder and Managing Director of Stallion AI Services said: "No one should be inseminating mares with imported semen that isn’t accompanied by the original health certificate. If the UK wants to retain its high health status and continue to utilise the international market it needs the breeding industry and the veterinary profession to use the disease controls that are currently place until such a time as we can implement more efficient system."
The BEVA says it is taking the following action:
Invetx specialises in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).
Dechra says these therapies have targeted modes of action and therefore are often more effective, provide an extended duration of activity and have fewer side effects, all of which help to extend and improve the quality of life for companion animals while decreasing the care burden for pet owners.
Jesper Nordengaard, Chief Executive Officer of Dechra, said: "I regard this acquisition as hugely important for Dechra, marking the start of a new chapter in our growth.
"It demonstrates our ambition to create further points of differentiation and relevance with veterinarians and pet owners alike, confidence in our ability to deliver highly innovative new products, and capacity to execute large scale transactions at speed."
Jesper added: “The half-life extension technology developed by Invetx allows for the generation of therapeutics that make treatment of chronic conditions far more convenient for pet owners and veterinarians through improved compliance.
"The pipeline of products currently being developed are all high value potential and will deepen our expertise in core therapeutic areas such as atopic dermatitis and osteoarthritis, allowing for synergistic product development, sales & marketing, and education efforts in the future.”
https://www.invetx.com
The authors say the research marks a significant step forward in understanding how veterinary surgeons and owners can more effectively manage and prevent outbreaks of the disease.
For the study, researchers from the RVC, the University of Cambridge, the Swedish University of Agricultural Sciences and Redwings Horse Sanctuary, analysed more than 500 S. equi samples from across the UK between 2016 and 2022.
In particular, they wanted to better understand the relative contribution of short-term (immediately post infection) versus long-term carriers (carriers that were infected months or years prior).
The samples were collected from clinical cases sent to diagnostic laboratories by veterinary surgeons seeking confirmation of infection.
Surplus samples were submitted to the Surveillance of Equine Strangles network and then cultured in the RVC’s research laboratory and their DNA extracted and sequenced to reveal each bacterium’s complete genetic code.
Adopting an approach that combined whole genome sequencing and epidemiological data, the researchers were able to trace how strains are related and have evolved.
With the use of computer programmes, they also tracked how genetically related strains spread between horses and across regions, over time.
By adopting this approach, the team was also able to pinpoint likely transmission events and chains of infection.
The main findings were:
The research highlights the need for early diagnosis, isolation and laboratory-confirmed clearance, particularly through guttural pouch testing, before assuming a horse is infection-free.
It also advocates for tighter biosecurity and movement protocols, especially when transporting horses across regions.
Dr Abigail McGlennon, former PhD student in the Department of Pathobiology and Population Sciences at the RVC, and lead author of the paper, said: “Strangles is a challenging and distressing disease for horses, owners, yards and vets, and this work has highlighted just how easily it can be spread across the UK in a short period of time.
“This study shows how important enhanced surveillance utilising epidemiological and genomic data is to investigate and understand strangles transmission across the UK.
"Our data highlights the importance of greater awareness and adoption of post-outbreak screening protocols to confirm freedom from infection, rather than owners assuming recovery based on the resolution of clinical signs.”
Novartis Animal Health has assumed marketing responsibilities for the joint health supplement Dasuquin in the United Kingdom and Ireland.
Dasuquin is a veterinary formulation developed to deliver advanced cartilage support in dogs. It contains a combination of glucosamine hydrochloride, chondroitin sulphate, avocado/soybean unsaponifiables (ASU), and tea polyphenols. Novartis says these compounds work synergistically to protect the cartilage, thereby playing an important role in supporting and maintaining joint health.
Novartis highlights a 2007 study which, according to the company, demonstrates that the combination of ASU, chondroitin sulphate, and glucosamine hydrochloride delivers incremental benefits compared to the combination of chondroitin sulphate and glucosamine hydrochloride alone.1
Dasuquin is available in flavoured chewable tablets in 80-count containers. Dasuquin is available in two strengths: small-to-medium dogs weighing between 5 and 25 kg and for large dogs weighing over 25 to 50 kg.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "This is a fitting addition to our overall orthopaedic health offering for vets and pet owners. Dasuquin brings vets and dog owners advanced joint health support with the next generation of the popular Cosequin family."
Dasuquin is available from Novartis Animal Health in the United Kingdom and Ireland from licensed veterinary wholesalers. For more information on Dasuquin, contact your Novartis Animal Health Territory Manager
Reference:
The RCVS has clarified its role concerning new UK veterinary schools, saying that it has no mandate to control student or graduate numbers.
Responding to calls from the profession that it should comment on the desirability of any change in the number of schools or graduates, the College has confirmed that whilst it is committed to setting, upholding and advancing the standards that any new UK veterinary degrees would need to meet in order to be approved by the Privy Council, it has no role in capping student numbers.
The College also points out that the free market and mobility of workers in the EU makes any control at the level of a sovereign state effectively meaningless with respect to workforce management. However, the College says it is committed to ensuring that standards are maintained, and to continue working with bodies such as the European Association of Establishments for Veterinary Education, which evaluates veterinary degrees across Europe.
The College also seeks to support healthy debate through providing information on the state of the profession - an example of which is the survey that it recently commissioned from the Institute for Employment Studies on job availability for veterinary graduates over the last five years.
The headline results from that survey were released in the summer, and showed that increasing graduate numbers over the last five years have so far appeared to have had little impact on veterinary job prospects, with 94% of graduate respondents seeking a role in clinical practice obtaining work within six months of starting to look.
The full RCVS Survey of Recent Graduates report is now available, and also shows that, of the 43% of veterinary surgeons who graduated in the last five years who responded:
The answers were analysed by year of graduation, veterinary school, age and gender, and the full report is available online at www.rcvs.org.uk/publications.
The Society of Practising Veterinary Surgeons (SPVS) has launched a new Profitability Survey to measure profitability levels across the nation’s veterinary practices and provide a benchmark for practices to assess their performance against.
Launched this month, the SPVS Profitability Survey is available to all practices, both members and non-members. It can be completed online using figures from the practice’s most recent set of accounts and the practice management system. All the data is kept completely confidential for practices to securely access their results online.
Once they have completed the survey, participating practices will be given an overall practice profitability score from excellent, good, average, below average and poor. Practices will also be able to benchmark against Key Performance Indicators such as: the cost of drugs and supplies; the cost of personnel; and cost of overheads.
Peter Brown, SPVS Treasurer and author of the survey said: "We’re particularly pleased to be launching this Profitability Survey. As the saying goes, turnover is vanity and profit is sanity. Profitability is key to any business yet we’re often told that veterinary practices fare badly when it comes to this fundamental point. Knowing how your business is performing and how it compares to others should be a priority for all practice principals and one that our new Profitability Survey will be able to answer.
"We are delighted to be working with John Sheridan on this subject. John has long been a passionate advocate of the need for practices to understand their profitability and he has helped SPVS to develop this simple survey to provide practices with the key statistics they need. Furthermore, the pooled, anonymised data will be used by SPVS to help us tailor CPD and expert advice for members on this critical aspect of their business. The more data we have the more accurate analysis we will be able to provide so we would urge all veterinary practices to complete the survey."
SPVS’ existing Fee and Salaries Surveys have also been enhanced with improvements to the way data is entered and results presented through a dedicated website developed with Veterinary Insights. Published earlier this year, the Salaries Survey revealed that there is a widening pay gap between newly qualified vets whose median salary actually fell by 3.7% and more experienced vets who attained increases of between 2.6% and 10.8%. However, while newly qualified vets compared favourably with their equivalents in the medical and dental profession, those more experienced lag some way behind.
To take part in the new SPVS Profitability Survey visit www.spvs.org.uk
Since 2014 the RCVS has trialled two different ADR services with the aim of helping resolve complaints between animal owners and veterinary practices that do not meet its threshold for serious professional misconduct.
Since October 2016, this has been in the form of the Veterinary Client Mediation Service (VCMS), administered by Nockolds Solicitors. The VCMS is free for both animal owners and veterinary professionals and cases will only be taken with the consent of both parties.
Eleanor Ferguson, RCVS Registrar, said: "We are very pleased that ADR in the form of mediation has received the unanimous support of RCVS Council members as part of the process for handling veterinary complaints.
"Throughout its trial period the VCMS has very much been complementary to our concerns investigation and disciplinary process. While we are bound by statute to investigate concerns, it has allowed our Professional Conduct Team to 'triage' cases, and to signpost complainants either to the College or the VCMS as appropriate. This has allowed greater time and resources to investigate concerns that could constitute serious professional misconduct.
"We also believe that the VCMS is good for both the public and the profession because it encourages both parties to communicate, find areas of agreement and come to constructive solutions, rather than being an adversarial process that assigns blame and adjudicates remedies."
Jennie Jones, a partner at Nockolds Solicitors which administers the VCMS, said: "The service is here to help veterinary clients and practices find a resolution for complaints that cannot be resolved within the practice. Complaints are referred to the VCMS by clients and practices where the relationship has become strained or communication may be difficult. Importantly the service does not look at who is right or wrong, but focuses on finding an outcome that both parties can live with and bringing an end to the complaint.
"In our experience this has ranged from reassuring clients and helping them to come to terms with what has happened, refunding fees, further explanations, apologies, small goodwill payments, securing procedural changes at the practice and agreement by the client to settle outstanding fees which have been withheld because of the complaint.
"We understand complaints are highly emotional and stressful for both parties, so the VCMS team will not ask parties to speak to one another directly. It is also not about assigning blame but is about moving forward to allow both parties to bring the complaint to a conclusion. When we hear from practices and clients alike that they can now sleep at night, or their relief that a complaint is resolved, I know ADR and the VCMS does help and make a difference."
The College says that during the trial period, 165 of the 870 enquiries received by the VCMS went to mediation. Of these, 129 were successfully mediated with the other 36 remaining unresolved. Of the other enquiries 297 resulted in the animal owner being referred back to the practice so that internal complaints processes could be exhausted first, 93 did not progress because the animal owner did not pursue the complaint, 73 were dealt with through advice, 66 did not progress as the practice declined to engage, 76 were outside the service’s remit and 100 are currently ongoing.
Taking into account the overall feedback received from both animal owners and veterinary professionals and the positive responses on the independence and fairness of the VCMS, Council agreed that Nockolds continue administering the scheme, with a review starting in 18 months’ time to take into account experience and learning as the scheme continues to evolve. During the Council meeting statements of support for the VCMS were also heard from a representative of the Veterinary Defence Society (VDS) and an independent consultant on consumer affairs.
A spokesperson for the VDS said: "The VDS assisted over 150 practices that agreed to participate in the ADR trial and developed a constructive working relationship with the VCMS staff. In the vast majority of cases mediation has resulted in a satisfactory outcome with little or no financial consequences.
"The Society considers this voluntary scheme particularly suited to the many client care complaints that are directed at the RCVS due to public misunderstanding of the College’s role, but the investigation of which creates disproportionate concern to the professionals involved. The independent nature of the VCMS has been a key feature of the trial, although access to experienced, non-judgemental, veterinary advice has provided the necessary professional expertise when necessary."
More information about the VCMS and its processes can be found on the service’s dedicated website: https://www.vetmediation.co.uk/
To contact the service directly call 0345 040 5834 or enquiries@vetmediation.co.uk